These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11689669)

  • 1. RNase H cleavage of the 5' end of the human immunodeficiency virus type 1 genome.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2001 Dec; 75(23):11874-80. PubMed ID: 11689669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.
    Driscoll MD; Golinelli MP; Hughes SH
    J Virol; 2001 Jan; 75(2):672-86. PubMed ID: 11134281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of internal cleavage sites by retroviral RNases H.
    Schultz SJ; Zhang M; Champoux JJ
    J Mol Biol; 2004 Nov; 344(3):635-52. PubMed ID: 15533434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription.
    Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN
    Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strand transfer events during HIV-1 reverse transcription.
    Basu VP; Song M; Gao L; Rigby ST; Hanson MN; Bambara RA
    Virus Res; 2008 Jun; 134(1-2):19-38. PubMed ID: 18279992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization.
    McWilliams MJ; Julias JG; Sarafianos SG; Alvord WG; Arnold E; Hughes SH
    Virology; 2006 May; 348(2):378-88. PubMed ID: 16473384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNase H activity of reverse transcriptases on substrates derived from the 5' end of retroviral genome.
    Ben-Artzi H; Zeelon E; Amit B; Wortzel A; Gorecki M; Panet A
    J Biol Chem; 1993 Aug; 268(22):16465-71. PubMed ID: 7688365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferred sequences within a defined cleavage window specify DNA 3' end-directed cleavages by retroviral RNases H.
    Schultz SJ; Zhang M; Champoux JJ
    J Biol Chem; 2009 Nov; 284(47):32225-38. PubMed ID: 19778906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNase H requirements for the second strand transfer reaction of human immunodeficiency virus type 1 reverse transcription.
    Smith CM; Smith JS; Roth MJ
    J Virol; 1999 Aug; 73(8):6573-81. PubMed ID: 10400754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
    Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
    Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of minus strand strong stop transfer in HIV-1 reverse transcription.
    Chen Y; Balakrishnan M; Roques BP; Fay PJ; Bambara RA
    J Biol Chem; 2003 Mar; 278(10):8006-17. PubMed ID: 12499370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo.
    Julias JG; McWilliams MJ; Sarafianos SG; Arnold E; Hughes SH
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9515-20. PubMed ID: 12093908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase.
    DeStefano JJ; Mallaber LM; Fay PJ; Bambara RA
    Nucleic Acids Res; 1993 Sep; 21(18):4330-8. PubMed ID: 7692401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro analysis of the HIV-1 second strand-transfer reaction.
    Pop MP
    Biochim Biophys Acta; 1996 Jun; 1307(2):193-204. PubMed ID: 8679705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Y181C mutant of HIV-1 reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors alters the size distribution of RNase H cleavages.
    Archer RH; Wisniewski M; Bambara RA; Demeter LM
    Biochemistry; 2001 Apr; 40(13):4087-95. PubMed ID: 11300789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that determine the efficiency of HIV-1 strand transfer initiated at a specific site.
    Rigby ST; Van Nostrand KP; Rose AE; Gorelick RJ; Mathews DH; Bambara RA
    J Mol Biol; 2009 Dec; 394(4):694-707. PubMed ID: 19853618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases.
    Smith CM; Potts WB; Smith JS; Roth MJ
    Virology; 1997 Mar; 229(2):437-46. PubMed ID: 9126256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer.
    McWilliams MJ; Julias JG; Sarafianos SG; Alvord WG; Arnold E; Hughes SH
    J Virol; 2003 Oct; 77(20):11150-7. PubMed ID: 14512562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence requirements for removal of tRNA by an isolated human immunodeficiency virus type 1 RNase H domain.
    Smith CM; Leon O; Smith JS; Roth MJ
    J Virol; 1998 Aug; 72(8):6805-12. PubMed ID: 9658129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.